Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma
Ying Liu,1,* Xin Wu,1,* Yuan Gao,2,* Jigang Zhang,1 Dandan Zhang,1 Shengying Gu,1 Guanhua Zhu,1 Gaolin Liu,1 Xiaoyu Li1 1Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 2Department of Pharmaceutics, Changhai Hospital, Second Military Medic...
Guardado en:
Autores principales: | Liu Y, Wu X, Gao Y, Zhang JG, Zhang DD, Gu SY, Zhu GH, Liu GL, Li XY |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e747f13235044edeb83ab312495a531b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease
por: Tang Y, et al.
Publicado: (2020) -
A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma
por: Zhao M, et al.
Publicado: (2018) -
La inhibición de Rho quinasa post infarto mejora el remodelado y la función ventricular: mecanismos involucrados a nivel preclínico
por: Mera,Claudia, et al.
Publicado: (2017) -
Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy
por: Do-Hun Kim, et al.
Publicado: (2021) -
Aptamer-Targeted Calcium Phosphosilicate Nanoparticles for Effective Imaging of Pancreatic and Prostate Cancer
por: Abraham T, et al.
Publicado: (2021)